Our medicines

Medicines commercialized by Juvisé Pharmaceuticals

10 medicines for patient use in nearly 80 countries

Below is a global list of products marketed by Juvisé Pharmaceuticals. The availability of medicines and the indications for which they are approved may vary with country and region.

For country-specific information, please contact us.

All medicationsNeuroscienceGastroenterologyOncologyCardiologyRheumatology
Arimidex® (anastrozole)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Casodex® (bicalutamide)

Please refer to the full prescribing information approved by the relevant national competent of the country where you are located.

For country-specific information, you may also contact us.

Digoxine-Juvisé® (digoxin)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Entumin® / Entumine® / Etomine® / Etumina® / Etumine® (clotiapine)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Esidrex® (hydrochlorothiazide)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Insidon® (opipramol)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Lumirelax® (methocarbamol)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Ponvory® (ponesimod)

The information and linked websites are intended for residents of the European Union only, as the availability of this medicine and the indications for which it is approved may vary with country and region.

Information on Ponvory® (ponesimod)

This medicine is under additional risk minimization measures. To obtain country-specific information or materials (Healthcare professional checklist, Patient/caregiver guide, Pregnancy-specific patient reminder card), please contact us at: ponvoryeducationalmaterial@juvise.com

If you are not a resident of European Union, please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Pylera® (bismuth subcitrate potassium + metronidazole + tetracycline hydrochloride)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

Sintrom® (acenocoumarol)

Please refer to the full prescribing information approved by the relevant national competent authority of the country where you are located.

For country-specific information, you may also contact us.

JUV-FRA-202408-0210, 09/2024

A question about one of our medicines?

If you have any questions about one of our medicines or if you would like to report an adverse event